Show simple item record

dc.contributor.authorMesseder, Sarah
dc.contributor.authorMusto, Liam
dc.contributor.authorSaratzis, Athanasios
dc.date.accessioned2024-06-26T09:43:19Z
dc.date.available2024-06-26T09:43:19Z
dc.date.issued2024-06-18
dc.identifier.citationMesseder, S. J., Musto, L., & Saratzis, A. (2024). Management of common femoral artery occlusive disease: the current gap in the evidence and future perspectives. The Journal of cardiovascular surgery, 10.23736/S0021-9509.24.13107-2. Advance online publication. https://doi.org/10.23736/S0021-9509.24.13107-2en_US
dc.identifier.other10.23736/S0021-9509.24.13107-2
dc.identifier.urihttp://hdl.handle.net/20.500.12904/18755
dc.description.abstractThe common femoral artery (CFA) is the most common site affected by peripheral artery disease. Due its various anatomical and morphological features, common femoral endarterectomy has long since been the preferred treatment option. However, there are complications associated with common femoral endarterectomy including, but not limited to, surgical site infections, hematoma formation, bleeding, and nerve injury. Unfortunately, this has been further complicated by the ageing population and increasing epidemic of obesity and diabetes mellitus. Within vascular surgery, there has been a rise in use of endovascular techniques for peripheral artery disease. Endovascular repair of the CFA is safe and feasible. One clear advantage is that they can be performed under local or regional anesthesia, thus reducing morbidity. This narrative review seeks to describe the current gap in the evidence and future perspectives in the management of common femoral artery occlusive disease.
dc.description.urihttps://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=R37Y9999N00A24061802en_US
dc.language.isoenen_US
dc.subjectcommon femoral artery (CFA)en_US
dc.subjectcommon femoral artery occlusive diseaseen_US
dc.titleManagement of common femoral artery occlusive disease: the current gap in the evidence and future perspectivesen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecordhttps:/doi.org/10.23736/S0021-9509.24.13107-2en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
html.description.abstractThe common femoral artery (CFA) is the most common site affected by peripheral artery disease. Due its various anatomical and morphological features, common femoral endarterectomy has long since been the preferred treatment option. However, there are complications associated with common femoral endarterectomy including, but not limited to, surgical site infections, hematoma formation, bleeding, and nerve injury. Unfortunately, this has been further complicated by the ageing population and increasing epidemic of obesity and diabetes mellitus. Within vascular surgery, there has been a rise in use of endovascular techniques for peripheral artery disease. Endovascular repair of the CFA is safe and feasible. One clear advantage is that they can be performed under local or regional anesthesia, thus reducing morbidity. This narrative review seeks to describe the current gap in the evidence and future perspectives in the management of common femoral artery occlusive disease.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record